XML 69 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Equity-Based Compensation - Additional Information (Details) - USD ($)
$ in Millions
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2021
Jul. 31, 2021
Sep. 30, 2021
Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Additional common units       2,000,000
Number of Profit Interests, Canceled and replaced with restricted stock       397,500
Additional recognized compensation expense       $ 14.0
Incremental equity-based compensation expense       $ 3.0
IPO and Organizational Transactions, units of unvested Profits Interests       1,771,767
Number of Options, Granted       2,292,309,000
Stock Options [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Unrecognized equity-based compensation expense       $ 19.8
Recognized over a weighted-average period       3 years 3 months 18 days
Number of Options, Granted as replacement awards       2,300,819
Number of Options, Granted       2,300,819
Stock Options [Member] | Minimum        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Vesting period     3 years 3 years
Stock Options [Member] | Maximum        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Vesting period       4 years
Restricted Stock Units [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Unrecognized equity-based compensation expense       $ 9.9
Recognized over a weighted-average period       1 year 8 months 12 days
Restricted Stock Awards        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Fair value of RSAs vested       $ 0.4
Restricted Stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Unrecognized equity-based compensation expense       $ 0.4
Recognized over a weighted-average period       1 year 4 months 24 days
Granted as replacement of Profits Interests, Number of Shares       137,691
2021 Employee Stock Purchase Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Common units holders       0
Common Class A        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Exchange of common units       854,807
Share Based Compensation Arrangement By Share Based Payment Award Options Grants as amended to be exercisable       1,212,124
Common Class A | Restricted Stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of Options, Granted as replacement awards       1,212,124
Granted as replacement of Profits Interests, Number of Shares       137,691
Rani Therapeutics Holdings Inc. [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of Options, Canceled and replaced       2,292,309
Number of Profit Interests, Canceled and replaced with restricted stock       (397,500)
Number of Options, Granted   2,292,309    
Rani Therapeutics Holdings Inc. [Member] | Common Class A        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of Options, Canceled and replaced       919,282
Exchange of common units 12,047,925     1,655,409
Common units holders       3,201,220
Common unit conversion basis In connection with the closing of the IPO, each LLC interest was exchanged 1 for 0.5282 as determined and predicated on the initial public offering price of the Company’s Class A common stock;     the remaining 64,475 Class A Units of Rani LLC continue to be outstanding and are exchangeable for the Company's Class A common stock at the option of the ICL Holders.
Conversion of stock, shares       1,545,522
Rani Therapeutics Holdings Inc. [Member] | Common Class A | 2021 Employee Stock Purchase Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Shares reserved for future issuance   500,000    
Rani Therapeutics Holdings Inc. [Member] | Common Class A | 2021 Equity Incentive Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Shares reserved for future issuance   5,500,000